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ABSTRACT 
In chemistry today, there is an ever growing and inevitable need to mass produce 
optically active starting materials for areas such as pharmaceutical and natural product synthesis.  
It is also important to modern chemists that these reactions are carried out under “green” 
conditions, which implies a significant reduction in the environmental impact of hazardous 
chemical production, storage, transportation, and waste disposal.  This project employs the use of 
biocatalytic enzymes to generate chiral alcohols and amines via the asymmetric reduction of 
ketones, imines, and oximes.  Initial reductions with prochiral ketones have yielded enantiomeric 
excess of >98%, with selectivity for either the (R) or (S) enantiomer depending on pea type.  In 
order to further examine the enzymatic reduction capabilities of various types of pea plants, a 
library of imines and oximes has been synthesized.  The library consists of prochiral imines, and 
oximes with an assortment of substituents, including molecules with electron donating and 
electron withdrawing groups.  Initial reductions of the aryl imines reveal that hydrolysis is a 
major competing reaction.  Biocatalytic reductions of the oximes have thus far been very 
successful and produced >99% e.e. with selectivity depending on pea type.  This is the first 
reported instance of biocatalytic oxime reductions. 
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CHAPTER 1: INTRODUCTION AND BACKGROUND 
The natural world of biological life is composed of a seemingly infinite complex 
intertwined with the building blocks of proteins and amino acids.  Enzymes function in this 
complex to actively assemble, disassemble, and modify implicit protein structures, which in 
return act as templates for biological processes.  Arguably the most crucial characteristic which 
ties the branches of the processes of life together is that of the innate chirality existent in plants, 
animals, humans, and all living things.  The concept of chirality, meaning the inability to be 
superimposed on its mirror image, is what dictates the functionality of a molecule, based on how 
it is oriented in three dimensional spaces.  It is often described as providing structures with a 
handedness, and most importantly is a key feature of what defines a molecule’s biological 
activity. 
Particularly in the human body, where pharmaceutical applications are concerned, 
chirality is a major part of what dictates how drugs will interact with the body.  Therefore, in 
order for pharmaceutical drugs to successfully fulfill their purpose, they need to posses the 
appropriate chirality which will cooperatively interact with the natural biological chirality. For 
example, as shown in Figure 1.1, simple inversion of the chiral center causes completely  
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Figure 1.1. Naproxen enantiomers.
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different functionalities for the Naproxen enantiomers.  While (S)-Naproxen is commonly used 
as an anti-inflammatory drug with analgesic and antipyretic properties, (R)-Naproxen is 
ineffective at combating these symptoms and is known to cause liver damage.1    
In the Organic & Biomolecular Chemistry journal, a study entitled “Analysis of the 
Reactions Used for the Preparation of Drug Candidate Molecules” examines details of the 
characterization and synthesis of drugs which were pre-selected by Medicinal Chemists.2   Of the 
128 drug candidate molecules analyzed, greater than 90% are small molecules (molecular weight 
less than 550 g/mol), greater than 90% contain a nitrogen atom, and 54% are chiral in nature. Of 
the 54% that are chiral, 97% are asymmetric, meaning that only one enantiomer is present.  It is 
common practice for pharmaceutical companies to have reactors that are utilized for multiple 
purposes, and therefore it is easier to facilitate the simple reactions of multiple complex 
fragments, rather to than build a singular more complex molecule in small fragments.  Chirality 
is then most commonly introduced in the early stages of synthesis via small molecules being 
added to the complex fragments.  These small molecules are most often purchased from 
industrial chemical companies.2  Therefore, as the applications of chirality in natural product 
synthesis increases, the demand for a larger, more diverse library of easily synthesized small, 
chiral, asymmetric molecules continues to grow and be of even greater importance (Figure 1.2). 
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Historically, methods that are capable of achieving a specific stereochemistry are termed 
stereospecific, and include both enantioselective and diastereoselective reactions.  These types of 
reactions are carried out in the presence of chiral additives and chiral auxiliaries, or involve the 
transfer of an achiral species.  Chiral additives and chiral auxiliaries consist of a broad range of 
substances and include cosolvents, photosensitizers, and catalysts.4  In order for a chrial additive 
or chiral auxiliary to be ideal, it must generate high selectivity, be easily removable from the 
desired product, have both pure enantiomers readily available, and lastly, be inexpensive to 
purchase.  Reactions that involve the transfer of an achiral species are termed “self-immolative” 
and are usually utilized in redox processes.  Common reaction methods which exploit the ability 
to induce stereoselectivity include: oxidations with osmium tetroxide, hydrogenations with 
Raney Nickel, and alkylations with LDA and alkyl halides (Scheme 1.1).4 
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By the 1970’s, the full importance of stereochemical reactions had been realized.  This 
realization was also partly due to the development of the necessary analytical tools to 
characterize the success of a reaction’s stereochemical control. These instruments, which for 
example include HPLC and NMR, revolutionized chemistry as a whole and especially served to 
further reinforce the role that asymmetric synthesis plays in past, present, and future natural 
product synthesis.4  
Of the asymmetric processes, reduction is perhaps the most valued and currently studied 
tool.  One of the first chemists to explore the asymmetric potential of various reductions was 
Vladimir Prelog. Prelog’s rule for reduction states that the hydride attacks from the re-face only 
of the prochiral ketone to furnish only (S) alcohols (Scheme 1.2).5  Implementation of this rule  
 
 
 
leads to the prediction of stereochemical outcomes when biocatalytic whole cells are used in the 
reduction. The ability to predict the resulting enantiomer in a reduction is extremely valuable 
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R
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when determining the best method to synthesize a desired enantiomer.  Vladimir Prelog and John 
Cornforth shared the Nobel Prize for their work in this area in 1975.7 
The processes of chemical catalytic asymmetric reductions have evolved and essentially 
centralized around rhodium complexes.  As early as 1966, Wilkinson found that the complex, 
chlorotris(triphenylphosphine)rhodium, functions as a catalysts in the hydrogenation of various 
alkene and alkyne substances.8  His group was the first to report a rhodium complex used as a 
true catalyst, where as in studies previous to this, the metal was not capable of catalysis without 
rapid deposition occurring.8  Shortly after this discovery, research involving catalytic rhodium 
rapid expanded to encompass reduction as well.  Today, the research surrounding rhodium 
catalysts has the goal of producing high selectivity in reductions of a broad range of molecules 
with various properties.4  The majority of the most common rhodium catalysts used in 
asymmetric reduction are rhodium-chiral phosphine catalysts which contain various ligand 
groups such as BINAP and BPPM (Figure 1.3).4  In addition to rhodium being used as a catalyst,  
 
 
 
 
more recently ruthenium has been found to be effective at facilitating asymmetric reductions as 
well.  Ruthenium also is most effective when used in correlation with various chiral phosphine 
ligands.9  Particularly Ru-BINAP catalysts are extremely valuable in the production of 
enantiomerically pure ketones because configuration is very predictable, meaning that the 
PPh2
PPh2 N
Ph2P
CO2Pr
O
PPh2
(R)-BINAP BPPM
Figure 1.3. Common ligands that complex with rhodium
and ruthenium to catalyze asymmetric reductions.
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catalyst used with (S)-BINAP usually gives (S)-alcohols in excellent ee of greater that 99% 
(Scheme 1.3).4   In the catalytic reduction process ligands generally serve the purpose of  
 
 
 
 
donating electrons to the coordinated central metal, and thereby activating it to bind to the 
substrate.  As for as reaction conditions for these types of reactions, all are carried out under 
hydrogen pressure, in dichloromethane or aqueous methanol as solvents and in some cases high 
temperatures of up to 100 °C shortened reaction time without significant loss of selectivity.9 
In addition to asymmetric reductions of ketones, the asymmetric reduction of imines to 
afford optically active amines is a very valuable, under studied process.  Like alcohols, amines 
are also precursors in many important natural product syntheses, meaning the need for 
enantiomerically pure amines is just as high.  Various rhodium complexes have proven to be 
successful in the reduction of imines, particularly the [RhCl(NBD)]2 complex with a mixture of 
sulfonated BDPP ((-)-(2S,4S)-2,4-bis(diphenylphosphino)pentane) at 20 °C in water-ethyl 
acetate  under hydrogen pressure provides greater than 95% e.e. (Scheme 1.4).9   
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Another commonly used method of reducing imines utilizes trichlorosilane with N-
picolinoylpyrrolidine or N-formyl derivatives as organic activators.10 These various derivatives 
provided up to 90% yield, with 80 % ee.  It is speculated that the basis for the successful 
coordinating of trichlorosilane to the organic activator is that the Si atom of the complex must 
coordinate with both the nitrogen atom of the picolinoyl group and the carbonyl oxygen (Figure 
1.4).10   
 
 
 
 
 
 
While chemical catalysis still maintains a vital role in asymmetric synthesis, a more 
recent trend in chemistry has turned towards exploring the potentials of biocatalysts.  
Biocatalysts have proven not only to be effective synthetic tools, but they are representative of a 
new category of approaches which require minimally toxic reagents, and do not produce 
hazardous waste.  The modern realization of the importance of minimizing the negative effects 
that humans have on the environment has impacted chemistry in a huge way and thus, “Green 
Chemistry” is now being explored more than ever.  The wide implementation of this type of 
chemistry would mean a significant reduction in the environmental impact of hazardous 
chemical production, storage, transportation, and waste disposal.   
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In many cases green, biocatalytic, synthetic methods cannot only be successfully 
implemented in place of chemical catalysis, but are in fact useful in some cases for carrying out 
processes which are difficult to accomplish with chemical catalysis. Over the past decade, the 
usage of biocatalysts has drastically increased, and in 2009, it was estimated that approximately 
10% of total drug synthesis processes depend on biocatalysts.11  In order to screen potentially 
suitable biocatalytic enzymes for reactivity, it is crucial to understand how they function.  For the 
reduction process, the coenzymes, NADH (nicotinamide adenine dinucleotide) and NADPH 
(nicotinamide adenine dinucleotide phosphate) and an enzyme function together to catalyze the 
reaction.  In the initial step of the process, the coenzyme and oxidized substrate bind to an 
enzyme.  Next, the substrate is reduced while simultaneously the coenzyme is oxidized.  In the 
final step, the coenzyme and reduced product detach from the enzyme and in effect the 
coenzyme is recycled and ready for the process to begin again.11  
The process by which the coenzyme is recycled back to its reduced form can vary 
depending on which hydrogen sources are most readily available in the reaction.  Some common 
example of hydride sources available to recycle the the coenzyme via reduction are alcohols, 
sugars, formic acid, certain amino acids, and also electric and light power sources.  For example, 
in the reduction of ketones by Candida magnolia, glucose and glucose dehydrogenase functioned 
to regenerate an active coenzyme by reduction (Scheme 1.5)11.  Photochemical methods also  
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Scheme 1.5. Recycling of NADPH using sugar for the reduction of a ketone.
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provide an environmentally friendly process to regenerate NAD(P)H, however, a few of the 
other methods utilized for this process are more environmentally hazardous and not 
economically preferable. For example, in order for electrochemical regeneration to be effective it 
requires an expensive and chemically hazardous rhodium complex.11  
As for the delivery of the hydride ion to the substrate being reduced, it can either attack 
the si-face or re-face of the carbonyl or imine group.  The face which is attacked depends on the 
distinctive orientation of the substrate-enzyme bond.  For different enzymes and different 
substrates, this orientation may be reversed, and therefore the selectivity for the (R) or (S) 
product can be controlled (Figure 1.5).11   
 
 
 
 
 
 
 
A more in depth look into the enzymes that are used to provide selectivity shows that 
there is much to be investigated and developed.   One of the first biocatalysts to be studied 
extensively for its applications in asymmetric reductions is baker’s yeast (Saccharomyces 
cerevisiae).  The reductase enzyme present in the yeast has been isolated, purified, and tested to 
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N
CONH2
H
R R'
OH
ADPHR
NAD(P)
Product
E1
E2
E3
E4
-E1, E2, E3, and E4 represent different types of enzymes.
Figure 1.5. Example of hydride transfer from coenzyme, NAD(P)H, to a carbonyl compound.
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show that it is very effective in the asymmetric reduction process for a wide variety of ketone 
substrates.12  More recent research with baker’s yeast has eliminated the extensive purification 
steps and the reductase genes have been expressed and cloned in Escherichia coli. The 
asymmetric reduction of 20 ketones have been successfully carried out with these recombinant E. 
coli cells and 11 of the alcohols produced were enantiomerically pure.13   
While the utility of baker’s yeast and many other microorganisms have been thoroughly 
studied and screened for use as biocatalysts, the enzymes derived from plants are virtually 
untouched potentially very valuable resources.  So far, most of the few plants that have been 
studied posess unique enzymes with interesting capabilities.  For example, vegetables such as  
carrot root (Ducus carota) have successfully been tested for the reduction of (+)-
camphorquinone to produce secondary alcohols in 88% yield (Scheme 1.6).14  However, a  
 
common problem that arises when using vegetables as biocatalysts is the effect of microbial 
contamination.  A recent study showed that when bacterial inhibitors were added to the reaction 
mixture, there was a sharp decrease in percent conversion and selectivity.  It can therefore be 
concluded that endophytic microorganisms, or microorganisms that share some sort of symbiotic 
relationship with the host organism, may be involved in the asymmetric reduction process when 
11 
 
certain plants are utilized as the enzyme carrier.11  This is a problem in biocatalysis because it 
means that not all vegetables of the same type, which contain the same enzymes, may be equally 
effective in asymmetric reduction due to a lacking presence of the second party microorganisms. 
In addition to D. carota, other common plants that have successfully been screened and 
tested as potential biocatalysts for the asymmetric reduction of ketones include: arracacha roots 
(Arracacia xanthorrhiza), beet roots (Beta vulgaris), yam tubers (Dioscorea alata), coriander 
roots (Coriandrum sativum), and turnip roots (Brassica rapa).  These are a few of the more well 
known plant biocatalysts and in the reduction of acetophenone derivatives, they provide decent 
percent conversion with typically high enantiomeric selectivity (Table 1.1).15  In order to achieve 
these high quality transformations, the plants were first washed with water prior to being soaked 
in a 5% sodium hypochlorite aqueous solution for 20 minutes. They were then rinsed with 
ethanol, peeled and cut to increase the surface area of the biocatalysts that the substrate could 
come into contact with.15 
 
 
 
 
 
 
In another recent study, sprouted green peas (Pisum sativa) were used for the first time as 
biocatalysts in the enantioselective reduction of prochiral ketones.  In correlation with the 
12 
 
previous study, these tests also examined the reduction of acetophenone derivatives in water.  
However, the procedure for these reductions utilized an aqueous buffer pH 7.0, and the reactions 
were only carried out for 24 hours in order to furnish the corresponding S-alcohols with ee 
ranging from 80-98%.5  Lastly, under similar conditions, other reductions of the same 
acetophenone derivatives with soaked Phaseolus aureus L as the biocatalyst showed that the 
presence of electron donating substituents on the attached aromatic rings of the ketones slow the 
reaction and produce relatively lower yields with moderate selectivity (Table 1.2).  However, this 
study successfully tested their method of reduction on a multi-gram scale, which consisted of 
using 500 g of the biocatalysts.16 
 
 
 
 
 
There is still much to discover regarding the biocatalytic activity of plants in the 
reduction of ketones to produce optically active alcohols, however, this area of research is 
expanding and only very recently have these procedural methods been applied to substrates other 
than ketones.  The asymmetric reduction of C=N bonds to generate enantiomerically pure amines 
via biocatalytic methods is virtually unexplored.  Efforts to change this fact have recently 
surfaced out of the sheer value and need for more efficient methods to produce enantiomerically 
pure amines for their vast applications in the pharmaceutical and agricultural industries.17  One of 
Substrate Product
% ee and
config.
% Yield
O
HO
OH
HO
72 (S) 23
O
H3CO
OH
H3CO
90 (S) 28
Table 1.2. Examples of decreased reaction rates
observed for substrates with electron donating groups.
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these studies utilizes the enzyme Candida parapsilosis ATCC 7330 in order to reduce a library 
of aromatic imines (Scheme 1.7).  The reductions were carried out using  
 
 
 
 
whole cells of the biocatalyst in an aqueous medium with no additional cofactor.  The results 
provided yields of up to 80% and e.e. of greater than 99% which was determined by chiral High 
Performance Liquid Chromatography (HPLC).  It should also be noted that substrates with 
electron withdrawing and electron donating groups were still produced in high yields with 
excellent ee.17  
While the biocatalytic studies over the reductions of imines are extremely minimal and 
underdeveloped, the literature on biocatalytic oxime reduction is seemingly nonexistent.  The 
reduction of oximes to primary amines requires the cleavage of the N-O bond in the molecule 
(Scheme 1.8).   Even catalytic methods capable of oxime reduction are fairly scarce.  However, a  
 
 
 
few well known methods involve processes using lithium aluminium hydride, sodium 
borohydride in the presence of various derivatives, diboranes with zinc and acetic acid, and a 
14 
 
more recent method  utilizes catalytic indium metal in solution with acetic anhydride, acetic acid 
and THF to facilitate reduction.18  Although, these methods have proven to be successful, if it is 
found in the future that a simple, nonhazardous, biocatalyst is capable of reducing oximes to 
their corresponding amines, it would most definitely become the preferred method. 
The world of chemistry as a whole and especially synthetic chemistry are developing at 
continually increasing rates each year, and as the modern world turns toward a “greener” more 
eco-friendly future, chemistry must turn there as well.  Therefore, further exploration of 
biocatalytic pathways is a major part of the chemistry of the future.  More extensive testing and 
implementation of these biocatalytic methods will help to fulfill the need that industry has for 
substrates such as, alcohols and amines, which are easily obtainable and enantiomerically pure.  
With the development of these processes, complex synthesis will be able to be carried out in an 
efficient, practical, and non-environmentally hazardous way. 
 
 
 
 
 
 
 
 
 
 
 
 
15 
 
References 
1) Drug Information Online. Drugs.com: Naproxen. 
http://www.drugs.com/pro/naproxen.html (accessed April 20, 2010). 
 
2) Carey, J. S.; Laffan, D.; Thomson, C.; Williams, M. T. Anaylsis of the Reactions Used 
for the Preparation of Drug Candidate Molecules. Org. Biomol. Chem. 2006, 4, 2337-
2347. 
 
3) Burns, A. R.; Taylor, J. K. Synthetic Approaches to Enantiomerically Enriched 4-
Hydroxycyclohex-2-en-1-one – A Key Chiral Building Block in Complex Natural 
Product Synthesis. Synthesis. 2011, 5, 681-707. 
 
4) Nogradi, M. Stereoseletive Synthesis, 2nd ed,; VCH Publishers, Inc: New York, New 
York, 1995. 
 
5) Yadav, J. S.; Subba Raddy, B. V.; Sreelakshmi, C.; Rao, A. B. Enantioselective 
Reduction of Prochiral Ketones Employing Sprouted Pisum sativa as Biocatalyst. 
Synthesis. 2009, 11, 1881-1885. 
 
6) Pscheidt, B; Glieder, A. Yeast Cell Factories for fine Chemical and API Production. 
Microbial Cell Factories. 2008, 7, 25. 
 
7) Nobelprize.org. The Nobel Prize in Chemistry 1975. 
http://nobelprize.org/nobel_prizes/chemistry/laureates/1975/. (accessed April 14, 2011). 
 
8) Osborn, J. A.; Jardine, F. H.; Young, J. F.; Wilkinson, G. The Preparation and Properties 
of Tris(triphenylphosphine)halogenorhodium(1) and Some Reactions thereof including 
Catalytic Homogeneous Hydrogenation of Olefins and Acetylenes and their Derivatives. 
Journal of the Chemical Society A: Inorgainc, Physical, Theoretical. 1966, 1711-1732. 
 
9) Ojima, I. Asymmetric Hydrogenation. In Catalytic Asymmetric Synthesis, 3rd ed.; John 
Wiley &Sons, Inc: Hoboken, New Jersey, 2010. 
 
10) Onomura, O.; Kouchi, Y.; Iwasaki, F.; Matsumura, Y. New organic activators for the 
enantioselective reduction of aromatic imines with trichlorosilane. Tetrahedron Letters. 
2006, 47, 3751-3754. 
 
11) Matsuda, T.; Yamanaka, R.; Nakamura, K. Recent progress in biocatalysis for 
asymmetric oxidation and reduction. Tetrahedron: Asymmetry. 2009, 20, 513-557.  
 
12) Ema, T.; Sugiyama, Y.; Fukumoto M.; Moriya, H.; Cui, J. N.; Sakai, T.; Utaka, M. 
Highly Enantioselective Reduction of Carbonyl Compounds Using a Reductase Purified 
from Baker’s Yeast. Journal of Organic Chemistry. 1998, 63, 4996-5000.  
 
16 
 
13) Ema, T.; Yagasaki, H.; Okita, N.; Takeda, M.; Sakai, T.  Asymmetric reduction of 
ketones using recombinant E. coli cells that produce a versatile carbonyl reductase with 
high enantioselectivity and broad substrate specificity. Tetrahedron. 2006, 62, 6143-
6149.  
 
14) Utsukihara, T.; Watanabe, S.; Tomiyama, A.; Chai, W.; Horiuchi, C. A. Stereoselective 
reduction of ketones by various vegetables. Journal of Molecular Catalysis B. Enzymatic. 
2006, 41, 103-109.  
 
15) Andrade, L. H.; Utsunomiya, R. S.; Omori, A. T.; Porto, A. L. M.; Comasseto, J. V. 
Edible catalysts for clean chemical reactions: Bioreduction of aromatic ketones and 
biooxidation of secondary alcohols using plants. Journal of Molecular Catalysis B: 
Enzymatic. 2006, 38, 84-90.  
 
16) Kumaraswamy, G.; Ramesh, S. Soaked Phaseolus aureus L: An efficient biocatalyst for 
asymmetric reduction of prochiral aromatic ketones.  Green Chemistry. 2003, 5, 306-308. 
 
17) Vaijayanthi, T.; Chadha, A. Asymmetric reduction of aryl imines using Candida 
parapsilosis ATCC 7330.  Tetrahedron: Asymmetry. 2008, 19, 93-96.  
 
18) Harrison, J. R.; Moody, C. J.; Pitts, M. R. Indium as a Reducing Agent: Reduction of 
Oimes. Synlett. 2000, 11, 1601-1602. 
 
 
 
 
 
 
 
 
 
 
 
 
17 
 
CHAPTER 2: BIOCATALYTIC REDUCTIONS OF PROCHIRAL KETONES 
Results and Discussion 
 As previously discussed, the utility of enantiomerically pure chiral alcohols extends deep 
into the core infrastructure of natural product synthesis. The ability to mass produce a wide 
variety of enantiomerically pure secondary alcohols is extremely valuable and furthermore to 
accomplish this in a “green”, environmentally friendly way is an even more highly coveted 
methodology.  This portion of the project explored the biocatalytic activity of a variety of pea 
seeds in the reductions of an assortment of ketones (Table 2.1, Figure 2.1). 
Pea Common Pea Name Family : Genus : Species 
A Pigeon Peas Fabaceae : Cajanus : cajan 
B Black Beans Fabaceae : Phaseolus : vulgaris 
C Navy Beans Papilionaceae : Phaseolus : vulgaris 
D Garbanzo Bean Fabaceae : Cicer : arietinum 
E Garden Peas (Split) Fabaceae : Pisum : sativum 
F Black Eyed Peas Fabaceae : Vigna : unguiculata 
Table 2.1. Pea and beans seeds tested as potential biocatalysts. 
 
 
While all of the peas tested provided high e.e. values, certain peas were more successful 
than others depending on the substrate being reduced.  In addition to excellent e.e. it was 
determined that the resulting stereochemistry could be controlled based on pea type.  It was also 
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determined that using a phosphate buffer in the reactions increased percent conversion.  Without 
the use of the buffer, the reaction mixture became fairly acidic and it was found that the enzymes 
responsible for reduction were not fully activated below a pH of 5.  Optimal reactions were 
determined to have a pH between 5.5 and 7.5.   
For all of the subsequent experimental reactions, conversion was determined via gas 
chromatography (GC), yield was taken after column chromatography purification, % e.e. was 
determined with chiral GC, and all values were averaged over 20 trials.  The first ketone 
substrate reduced was acetophenone and the peas responsible for the best results in selectively 
producing each of the enantiomers was, pea F which gave 78% conversion and 97% e.e. of the 
(S) enantiomer, and pea B which gave 78% conversion and 97% e.e of the (R) enantiomer 
(Scheme 2.1, Table 2.2). 
 
 
 
 
 
 
 
 
 
 
In the reduction of 4-chloroacetophenone the pea responsible for yielding the most 
enatiomerically pure (S) alcohol varied from that of acetophenone. In this case, the most 
Table 2.2. Acetophenone reductions with the biocatalytic peas.
Pea % Conversion % Yield % e.e.
A 88% 81% 95% (S)
B 81% 77% 97% (R)
C 90% 85% 90% (S)
D 74% 70% 93% (S)
E 80% 77% 88% (S)
F 79% 74% 99% (S)
O OH OH
RS
Scheme 2.1. Example reduction of acetophenone.
Pea A - Whole Seeds
H2O, rt, 48 h
Phosphate buffer, 7.2 pH
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successful reductions came from, pea A which gave 82% conversion and 97.5% e.e of the (S) 
alcohol, and pea B which gave 81% conversion and 95% e.e. of the (R) alcohol (Scheme 2.2, 
Table 2.3). 
 
 
 
 
 
 
 
 
  
For the reduction of 4-methoxyacetophenone, pea A was the most effective at producing 
the (S) enantiomer and furnished 88% conversion with 98% e.e.  The highest selectivity for the 
(R) enantiomer was again achieved by pea B which yielded 85% conversion and 93% e.e 
(Scheme 2.3, Table 2.4).  It should also be noted that in this case, the presence of the methoxy 
electron donating substituent did not seem to influence the effectiveness of either the progression 
of the reaction or its selectivity. A previous study in the biocatalytic, asymmetric reduction of 
ketones with soaked Phaseolus aureus L attested that only moderate selectivity could be 
achieved with low yields when electron donating groups were present on the attached aromatic 
ring of the ketone.1   
Table 2.3. 4-Chloroacetophenone reductions with the biocatalytic peas.
Pea % Conversion % Yield % e.e.
A 82% 81% 97.5% (S)
B 81% 71% 95% (R)
C 68% 55% 88% (S)
D 71% 60% 91% (S)
E 78% 64% 88% (S)
F 79% 69% 92% (S)
O OH OH
RS
Scheme 2.2. Example reduction of 4-chloroacetophenone.
Cl Cl Cl
Pea A - Whole Seeds
H2O, rt, 48 h
Phosphate buffer, 7.2 pH
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In order to explore a wider variety of ketones that were not acetophenone derivatives, the 
reductions of 4-phenyl-2-butanone were examined (Figure 2.5). For these reactions, pea F gave 
the highest e.e. of 94% with 80% conversion for the (S) enantiomer, and pea B yielded the best 
results for the (R) enantiomer with 90% e.e. and 78% conversion (Table 2.5).  These particular 
ketone reductions generally demonstrated slightly lower % e.e values than the previously studied 
acetophenone derivatives.  This is most likely attributed to the implicit structural properties of 
the ketone itself.  By having the longer alkane chain separating the phenyl and ketone 
functionalities, there is more opportunity for free rotation meaning, less steric restrictions which 
function to retain the rigidity of the molecule.  Retention of the rigidity of the molecule enables 
the enzyme complex to maximize the selectivity of its approach to the ketone substrate, 
therefore, the less rigid the molecule being reduced, the less selective the reduction process. 
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In the reductions of 2-octanone, pea A provided the best results for the (S) enantiomer 
with 87% e.e. and 65% conversion, while pea B provided 70% e.e. with 78% conversion for the 
(R) enantiomer (Figure 2.6, Table 2.6).  As such was the case with 4-phenyl-2-butanone, the 
enantiomeric purity of the reductions were lower for 2-octanone as compared to what was 
achieved with the acteophenone derivatives.  Of the six ketone substrates examined, 2-octanone 
afforded the lowest e.e. values, which is again most likely due to the lack of rigidity of the 
molecule.  The linear chain alkane structure of 2-octanone has diminished conversion and e.e. 
which could be due to poor binding to the enzyme active site. 
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In the reductions of 1-indanone, pea C afforded the highest selectivity for the (S) 
enantiomer with 99% e.e. and 79% conversion, and pea B the highest selectivity for the (R) 
enantiomer with 94% e.e and 78% conversion (Figure 2.7, Table 2.7).  As compared to the 
previous two non-acetophenone derivatives, 1-indanone has a cyclic structure bound to a phenyl 
ring, which maintains and fairly strict rigidity, and therefore extremely high % e.e. values were 
obtained for a variety of the pea enzymes tested. 
 
 
 
 
 
 
 
 
Another interesting observation is that the same pea type did not produce all of the 
highest % e.e. values for the (S) alcohols.  This indicates that different enzymes from the 
particular peas are interacting with each ketone substrate in a unique way. For example, because 
pea F furnished the highest % e.e. in the reduction of acetophenone to its (S) alcohol, and pea A 
furnished the highest % e.e in the reduction of 4-chloroacetophenone to its (S) alcohol, it can be 
concluded that the enzyme or active site responsible for reduction varies from pea to pea and 
therefore, different enzymes are optimal for the reduction of different substrates.  If the particular 
enzymes responsible for reduction were known, hypotheses could potentially be made based 
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upon steric interactions or electronic effects, however, further research into the implicit enzyme 
properties would need to be understood first.  This leaves a huge potential for further research 
into more of the enzymatic functionalities and properties which control these reactions.  
   The obvious anomaly that appeared in all of the ketones tested was that of the reverse 
selectivity achieved by pea B.  It is very well known, according to Prelog’s Rule for reduction 
that the hydride attacks from the re-face of the prochiral ketone to furnish only (S) alcohols.2 
However, the enzymes in pea B seem to have defied this concept by producing the (R) alcohols.  
In order to obtain an inversion of the chiral center, there needs to be a property of the enzyme to 
substrate binding complex which blocks the re-face of the prochiral center and makes the si-face 
more favorable for hydride attack.  Again, without structural knowledge of the enzyme itself, it is 
difficult to make assumptions about its particular binding functionalities, but it is clear the 
inherent structural properties of the reductase enzymes in pea B poses unique qualities from that 
of the other pea reductase enzymes explored.  
The first step towards isolating the enzymes responsible for the reduction process was to 
determine which part of the pea itself contains the enzymes.  This was done by running the 
reduction reactions with the pea cores and pea shells separately.  These experiments resulted in 
reductions that were run with pea core yielding up to 99% e.e. and 83% conversion to the (R) 
enantiomer with pea F.  On the other hand, the reductions run with pea shells only yielded 20% 
e.e and 68% conversion to the (R) enantiomer with pea F.  This data clearly demonstrates that 
more of the enzymes responsible for reduction reside in the pea core and not the pea shell.  
In addition to exploring the location of the enzymes responsible for reduction, potential 
pathways to minimize the ratio of pea to millimole of substrate were also explored.  In the 
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methodology utilized for these experiments, it is speculated that there is actually excess enzyme 
present within the 25 g of peas than what is being utilized to reduce the 1 mmol of substrate, 
however, the concentration of coenzyme (NAD(P)H) is depleting at a faster rate.  Without a 
source of coenzyme or the means to regenerate it, the catalytic process stalls.3  While adding 
excess coenzyme or employing a means to regenerate it would potentially help to maximize the 
usage of the total enzyme present, these techniques are either expensive or environmentally 
hazardous.   
The most interesting and innovative result that came from these various reductions is the 
ability to control selectivity for a particular enantiomer based solely on pea type used.  The 
ability to effectively control selectivity is one of the most highly regarded methodologies in 
chemistry and to be able to do it simply by switching the type of pea seed used is by far more 
efficient, more cost effective, and less environmentally hazardous than any other method 
previously available.  For example, in the chemical, asymmetric, reductions of ketones, the 
commonly used toxic rhodium catalyst, Benzeneruthenium(II) chloride dimer, cost $153.40 per 
0.5 g according to Sigma-Aldrich.4  It is therefore feasible that with further development of the 
enzymatic properties of the peas, that biocatalytic pea reductions could prove to be extremely 
applicable. 
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Experimental  
General Method for Biocatalytic Reduction of Ketones.  
The ketone (1.00 mmol) was added to a suspension of peas (25-30 g) in water (50 mL) or 
phosphate buffer (50 mL, pH 7.1). The container was sealed and shaken for 48 h.   The reaction 
mixture was vacuum filtered to remove the pea/bean solids. The pea/bean solids were washed 
with water (2 x 20 mL) and ethyl acetate (2 x 20 mL).  The biphasic filtrate solutions were 
combined and extracted with ethyl acetate (2 x 20 mL).  The organic layer was isolated, dried 
with Na2SO4, filtered and evaporated under reduced pressure. The crude oil was analyzed for 
percent conversion and e.e.  The oil was purified by column chromatography (hexanes:EtOAc) 
to yield the purified alcohols.  All spectroscopic data for the alcohols was compared to literature 
data for the previously reported compounds. 
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CHAPTER 3: PREPARATION OF IMINES AND OXIMES AND BIOCATALYTIC 
REDUCTIONS 
Results and Discussion 
 In contrast to biocatalytic reductions of ketones, there is only one reported literature 
reference for the biocatalytic reduction of imines, and there is not a current literature reference 
for the biocatalytic reduction of oximes.  This means that there is a tremendous amount of 
uncharted territory in the area of exploring potential biocatalytic enzymes and their effectiveness 
in asymmetric reductions of imines and oximes.   
 In order to examine the capabilities of the pea enzymes toward asymmetric reduction of 
imines, the imines first needed to be synthesized.   The methodology used for the synthesis of 
five biaryl imines was derived from a previously reported methodology which utilized a 
microwave reactor to condense various acetophenone and aniline derivatives (Scheme 3.1).1  
However, the literature proved to not be as effective as reported in our hands, and in reality, 
multiple microwave heating cycles and multiple additions of the aniline derivatives supplied the 
best yields of up to 80%. 
 
  
 
While the microwave condensation method gave a broad range of yields, once developed, 
it was a fairly facile synthesis and extremely economically efficient as compared to other 
previously reported methods which required expensive catalysts and harsh reaction conditions. 
For example, a previous method required that the reaction to be carried out with dry solvents 
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under nitrogen pressure in the presence of a titanium tetrachloride catalyst at -30 °C.2  Expensive 
reagents, harsh conditions, and long reaction times were not required for the microwave 
condensations which, in some cases, were even prepared neat and reaction times consisted of 
only three 15 minute heating cycles. 
 In testing the capabilities of the biocatalytic enzymes in peas toward asymmetric 
reduction of the synthesized imines, hydrolysis back to the respective acetophenone and aniline 
derivatives was consistently found to be the primary reaction taking place, not reduction 
(Scheme 3.2).    
 
Hydrolysis was the primary reaction because the mixture became too acidic during the shaking 
period, which caused formation of an iminium ion, making it highly susceptible to attack from 
water.  The reaction mixture became acidic because the enzymes, coenzymes, and plant materials 
in the peas were slowly released into solution during the course of reaction.  In order to combat 
hydrolysis by stabilizing the pH of the mixture, a variety of buffers were tested.  The buffers 
tested include sodium phosphate buffers at 0.1 M and 0.2 M concentrations and a Tris buffer.  Of 
the numerous trials conducted utilizing these buffers with a variety of pea types and imine 
substrates, the only instance that showed slight reduction of the imine to the secondary amine 
was observed with the 0.2 M sodium phosphate buffer (Figure 3.1).  The GC-MS figure also 
shows that after hydrolysis took place, the pea enzymes did function to reduce the acetophenone 
N HN
NH2
O OH
Pea A, H2O, 24 h
Imine Hydrolysis
Scheme 3.2. Example of imine hydrolysis.
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that formed to produce the corresponding alcohol.  This evidence shows that the pea enzymes 
capable of reduction are present and active however, the issues are arising with the imine 
substrate itself. 
 
 
 
 
 
 
 
 
 
Another possibility as to why the imines are not reducing is that they are potentially too 
sterically hindered for the enzyme complex to bind properly in order for reduction to take place.  
Therefore, the biaryl groups are not ideal for biocatalytic reductions for two reasons; the phenyl 
groups function to further activate the imine nitrogen which leads to hydrolysis, and there are 
larger groups which may be sterically preventing the desired reduction reaction all together.  
Future research entails the synthesis of less electron donating, less sterically hindered imines, for 
example using methyl amine instead of aniline (Scheme 3.3). 
O
Cl
H2N
HN
Cl
OH
Cl
HN
Cl
m/z: 231
231
Figure 3.1. Biocatalytic imine reduction GC-MS.
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Should the approach of using less sterically hindered amines to synthesize imines afford 
decent reduction results, the biocatalytic method would be superb in many ways, as compared to 
chemical asymmetric reduction methodology.  For example, a previous chemical method utilized 
the chiral catalyst, cyclooctadiene (cod) dimer [Rh(cod)Cl]2 and sulfonated-BDPP under 
hydrogen pressure (70 bar) to asymmetrically reduce imines (Scheme 3.4).3  According to 
Sigma-Aldrich the chiral catalyst costs $207.00 per 0.5 grams and the BDPP prior to sulfonation 
costs $147.50 per 0.5 grams.4,5   
 
 
 
 
As for synthesis of the oximes, they were easily produced in high yields of up to 98%.6  
In the biocatalytic reductions, the reaction mixture again became acidic, however oximes are not 
as prone to hydrolysis as biaryl imines.  The oxime structure is also not as sterically hindered 
around the C=N bond as compared to the biaryl imine structures, which may aid in making it less 
resistant to reduction. Because the reaction solution became acidic during the reduction, when 
the oxime reduced to its corresponding free amine, the amine became protonated and therefore 
water soluble.  In order to ensure that the amine could be fully extracted from the reaction, the 
N Ph N
Ph
PPhAr2PPhAr2
SO3Na
H2, [Rh(cod)Cl]2, sulfonated-BDPP
Ar =
,
Scheme 3.4. Chemical reduction of imines.
O N
Molecular Sieves
Microwave
R = H, Cl, OMe. NO2
Scheme 3.3. Examples of less sterically hindered imines.
NH2CH3
RR
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solution was neutralized to pH 10 prior to extraction (Scheme 3.5, Table 3.1).  Thus far, only 
three peas (B, C, and E) have been tested and up to 95 % e.e. has been achieved utilizing pea E.  
As such was the case with the previously examined ketones, pea B appears to again demonstrate 
reverse selectivity by providing the (R) enantiomer, while the other peas appear to produce fairly 
selectively the (S) enantiomer.  Configurational assignments were determined by optical rotation 
measurements as compared to authentically prepared samples. 
 
 
 
 
 
 
Future work with the oximes will consist of bringing the data up to par with what was 
obtained for the ketone reductions.  This consists of exploring the effects that the electron 
donating and electron withdrawing substituents have on the reduction process, and if the trend of 
reverse selectively continues for all pea B reactions.  Again, the ability to selectively control 
which enantiomer is produced simply by changing the pea type used in the reaction, is by far 
more simplistic than other reported methodologies which utilize expensive chiral catalysts. 
To make this biocatalytic process applicable for industrial purposes, collaborations with 
biochemists would need to be made in order to further explore the enzymatic properties of the 
peas.  If the enzymes responsible for reduction were isolated, then they could potentially be 
Scheme 3.5. Biocatalytic oxime reduction and acylation process.
N
OH
NH2
Pea B, C, E
NH
O
(AcO)2,
Pyr
Amides: 4a
Table 3.1. Oxime 2a reduction results for peas A, B, and C.
H2O,Tris buffer, rt, 72 h
Oxime: 2a
Pea % Conversion % e.e. Configuration
B TBA 85 R
C 83 67 S
E 72 95 TBD
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cloned and expressed in bacteria such as E.coli.  The reductase infused E. coli could then be 
replicated to produce large portions of pure active enzyme.  This process has been successfully 
completed on the enzyme responsible for reduction in baker’s yeast.7  With successful 
completion of this process would come the ability to effectively reduce a large amount of 
substrate with only very small portions of the pure enzyme. 
While this project has taken steps toward uncovering the vast capabilities of biocatalytic 
enzymes, there is still much to be discovered and much work to be done.   There are still 
countless enzymes to be screened and processes to test.  The use of the biocatalytic enzymes in 
peas toward asymmetric reduction thus far has not only proven to be effective, but it represents a 
new era of “green chemistry”.   The implementation green processes into routine synthetic 
reactions is instrumental for the future of modern chemistry and is a field only at the brink of 
exploration. 
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Experimental 
General.  All microwave reactions were carried out utilizing a CEM Explorer microwave at 
power 150.  Molecular sieves (4 Å) were first activated prior to use in all microwave reactions.  
Reactions were monitored by GC-MS (Agilent 6850, 5975C detector, Agilent HP-5MS, 30 m x 
0.25 mm, 0.25 mm film column) and TLC on silica gel 60 F254 (0.25 mm, E. Merck). Spots were 
detected under UV light or by staining with p-anisaldehyde.  Chromatography was performed on 
silica gel 60 (40-60) µM). All GC-MS spectra were run with an equivalent method, as shown in 
Appendix 1. Solvents were evaporated under reduced pressure at below 45 °C (bath). 1H NMR 
spectra were recorded at 250 MHz, and chemical shifts are referenced to TMS (0.0, CDCl3).  13C 
NMR spectra were recorded at 62.9 MHz, and are referenced to TMS (0.0, CDCl3).  The general 
procedure for the imine synthesis reactions was developed from a previously reported 
methodology.1 Specific reaction variations in imine synthesis are given in Table 3.2.  Product 
yields and appearances of imines are given in Table 3.3.  Imines 1a, 1b, and 1c have previously 
been synthesized and characterized.1  The procedure used to synthesize the oximes has been 
previously reported.6   Product yields for oximes are given in Table 3.4.  All oximes have been 
previously synthesized and characterized.8, 9, 10 
Imine Synthesis 
Method A. Acetophenone (25.6 mmol) and aniline (38.5 mmol) in the presence of 
molecular sieves (4 Å) were condensed using a microwave oven (Power 150) (Scheme 3.6, Table 
3.2).  After each heating cycle, aniline (25.6 mmol) was again added to the reaction and heated 
for another cycle.  The progression of the reaction was monitored by GC-MS and TLC for the 
disappearance of acetophenone.    The crude product was purified via chromatography (1% 
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triethylamine in petroleum ether) to yield the imine products 1a or 1b (Table 3.3).  For best 
results, the silica gel column was first prepared with 10% triethylamine in petroleum ether and 
allowed to set for 24 h prior to flushing the column with the 1% triethylamine solution. 
Method B. Acetophenone (25.6 mmol) and aniline (38.5 mmol) in the presence of 
molecular sieves (4 Å) were condensed in toluene (3 mL) using a microwave oven (Power 150) 
(Scheme 3.6, Table 3.2).  After each heating cycle, aniline (25.6 mmol) was again added to the 
reaction and heated for another cycle.  The progression of the reaction was monitored by GC-MS 
and TLC for the disappearance of acetophenone.  The crude product was purified via 
chromatography (1% triethylamine in petroleum ether) to yield the imine product 1c or 1d (Table 
3.3).  For best results, the silica gel column was first prepared with 10% triethylamine in 
petroleum ether and allowed to set for 24 h prior to flushing the column with the 1% 
triethylamine solution. (1d) as a mix of E and Z isomers: Rf 0.89 (7:1, petroleum ether: EtOAc); 
1H NMR (250 MHz, CDCl3, δH) 7.88-7.84 (m, 2 H), 7.37-7.23 (m, 3 H), 7.22-7.13 (m, 2 H), 
6.65-6.50 (m, 2 H), 2.13-2.12 (m, 3 H); 13C NMR (62.9 MHz, CDCl3, δC) 166.2, 150.2, 139.2, 
130.7, 129.0, 128.5, 128.4, 127.2, 120.8, 17.4.  
Method C. Acetophenone (25.6 mmol) and aniline (38.5 mmol) in the presences of 
molecular sieves (4 Å) were condensed in toluene (3 mL) using a microwave oven (Power 150) 
(Scheme 3.6, Table 3.2).  After the heating cycle, aniline (25.6 mmol) was again added to the 
reaction and heated for another cycle with the progression of the reaction being monitored by 
GC-MS and TLC for the disappearance of acetophenone.    The crude product was purified via 
chromatography (1% triethylamine in petroleum ether) to yield the imine product 1e (Table 3.3).  
For best results, the silica gel column was first prepared with 10% triethylamine in petroleum 
ether and allowed to set for 24 h prior to flushing the column with the 1% triethylamine solution.  
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(1e) as a mix of E and Z isomers: Rf 0.74 (7:1, petroleum ether: EtOAc); 1H NMR (250 MHz, 
CDCl3, δH) 8.32-8.26 (m, 2 H), 8.16-8.05 (m, 2 H), 7.41-7.34 (m, 2 H), 7.17-7.10 (m, 1 H), 6.82-
6.70 (m, 2 H), 2.29-2.28 (m, 3 H); 13C NMR (250 MHz, CDCl3, δC) 163.6, 150.8, 148.9, 145.0, 
129.1, 128.1, 123.9, 123.5, 119.1, 17.5.
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Oxime Synthesis. A mixture of acetophenone (37.0 mmol), hydroxylamine hydrochloride (57.8 
mmol), 95% ethanol (10 mL) , and water (2 mL) was stirred at rt.   To this mixture crushed 
sodium hydroxide pellets (7.26 g, 181.48 mmol) were added in small portions with vigorous 
stirring. The reaction was refluxed (5 min) and after cooling was poured into a solution of 
concentrated hydrochloric acid (6 mL) and water (40 mL).  The resulting precipitate was vacuum 
filtered, washed with cold water (2 x 10 mL), and dried to yield oxime 2b, 2c, or 2d (Scheme 
3.7, Figure 3.3, Table 3.4).  
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Racemic Reductions of Imines. Cl3SiH (1.5 mmol) was added to a solution of 1a, 1b, 1c, 1d, or 
1e (1.0 mmol), and 1-formylpyrrolidine (0.1 mmol) in dicholoromethane (5.0 mL). The resulting 
solution was allowed to let stir at rt for 5 days.  The reaction solution was then neutralized with 
sodium bicarbonate (5 mL) and extracted with dichloromethane (2 x 50 mL).  The organic layer 
was dried with Na2SO4 and concentrated to dryness.  The resulting amine, aceticanhydride (2.0 
eq), pyridine (2 mL), and dichloromethane (3 mL) were reacted in a microwave for 10 min at 60 
°C.  The resulting solution was quenched with water (10 mL) and extracted with 
dichloromethane (2 x 50 mL).  The combined organic layer was dried with Na2SO4 and 
concentrated to dryness. The crude product was purified via chromatography (5:1, petroleum 
ether/EtOAc) to yield amide 3a, 3b, 3c, 3d, or 3e (Scheme 3.8, Figure 3.4, Table 3.5).  This 
methodology was previously reported in the literature.11   
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Racemic Reduction of Oximes.  A solution of oxime 2b (1.38 mmol) in ethanol (25 mL) and 
concentrated hydrochloric acid (1 mL) was hydrogenated at atmospheric pressure in the presence 
of 10% Pd/C (50 mg) for 24 h.  The reaction mixture was filtered through Celite and 
concentrated to dryness. The product was then taken up in ethanol (25 mL) and again 
concentrated to dryness.12  The resulting product, acetic anhydride (2.0 eq), and pyridine (2 mL) 
were reacted in a microwave for 10 min at 60 °C.  The solution was quenched with water (10 
mL) and extracted with dichloromethane (2 x 50 mL).  The combined organic layer was dried 
with Na2SO4 and concentrated to dryness. The crude product was purified via chromatography 
(5:1, petroleum ether/EtOAc) to yield 1-phenylethanamine as a racemic mixture (Scheme 3.9).  
 
 
Scheme 3.9. Example of racemic oxime reduction and acylation process.
N
OH NH2
H2, 10% Pd/C
NH
O
(AcO)
2
,
Pyr
Amides: 4a, 4b, 4c
EtOH, HCl
Oxime: 2b
Cl
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General Method for Biocatalytic Imine Reductions. Pea A, B, C, D, E, or F (25.0 g) was 
added to water (100 mL) and allowed to soak for 24 h (Table 3.6). The water was then decanted 
and imine 1a, 1b, 1c, 1d, or 1e, tris buffer (10 mL), and water (40 mL) were added to the pea 
mixture and it was placed on an orbital shaker for 72 h.  The liquid solution was decanted away 
from the peas and then neutralized with sodium hydroxide to pH 10. The solution was then 
extracted with ethyl acetate (2 x 50 mL) and the organic layer was separated, dried with Na2SO4, 
filtered and concentrated. The resulting products consisted of the respective acetophenone and 
aniline derivatives.  The results of these hydrolysis reactions were confirmed by GC-MS and 
TLC (Scheme 3.10). 
Pea Common Pea Name Family : Genus : Species 
A Pigeon Peas Fabaceae : Cajanus : cajan 
B Black Beans Fabaceae : Phaseolus : vulgaris 
C Navy Beans Papilionaceae : Phaseolus : vulgaris 
D Garbanzo Bean Fabaceae : Cicer : arietinum 
E Garden Peas (Split) Fabaceae : Pisum : sativum 
F Black Eyed Peas Fabaceae : Vigna : unguiculata 
Table 3.6. Pea and beans seeds tested as potential biocatalysts. 
 
 
General Method for Biocatalytic Oxime Reductions. Pea B, C, or E (25.0 g) was added to 
water (100 mL) and allowed to soak for 24 h (Table 3.6). The water was then decanted and 
oxime 2a, tris buffer (10 mL), and water (40 mL) were added to the pea mixture and it was 
placed on an orbital shaker for 72 h.  The liquid solution was decanted away from the peas and 
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then neutralized with sodium hydroxide to pH 10. The solution was then extracted with ethyl 
acetate (2 x 50 mL) and the organic layer was separated, dried with Na2SO4, filtered and 
concentrated. The resulting amine was confirmed by GC-MS and TLC. Next, the amine, acetic 
anhydride (2.0 eq), pyridine (2 mL), and dichloromethane (3 mL) were reacted in a microwave 
for 10 min at 60 °C.  The resulting solution was quenched with water (10 mL) and extracted with 
dichloromethane (2 x 50 mL).  The organic layer was dried with Na2SO4 and concentrated to 
dryness. The crude product was purified via chromatography (3:1, petroleum ether/EtOAc) to 
yield amides 4a, 4b, or 4c (Scheme 3.11, Table 3.7). Enantiomeric excess was determined by 
Shimadzu LC-10 standard phase HPLC using low pressure gradient mixing and manual injection 
of 5 µL on a Ciracel AD-H column from Daicel Chemical Industires, LTD. All samples were 
resolved under AS-H, 40°C, 5% iPrOH/Hex, 1 mL/min conditions. 
 
 
 
Scheme 3.11. Example of biocatalytic oxime reduction and acylation process.
N
OH
NH2
Pea B, C, E
NH
O
(AcO)2,
Pyr
Amides: 4a, 4b, 4c
Table 3.7. Biocatalytic reduction and acylation from oxime 2a to form amides 4a-4c.
H2O,Tris buffer, rt, 72 h
Oxime: 2a
Product
umber
Pea
Product
Mass
% Yield % Conversion % e.e. Configuration
4a B 0.0306 g 19 TBD 85 R
4b C 0.0761 g 46 83 70 S
4c E TBD TBD 72 95 TBD
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APPENDIX I: GC-MS METHOD PARAMETERS 
 
OVEN 
Initial temp: 50 'C (On) Maximum temp: 325 'C 
Initial time: 0.00 min Equilibration time: 0.50 min 
Ramps: 
# Rate Final temp Final time 
1 20.00 250 6.00 
2 0.0(Off) 
Post temp: 0 'C 
Post time: 0.00 min 
Run time: 16.00 min 
INLET (SPLIT/SPLITLESS) DETECTOR (NO DET) 
Mode: Split Temperature: 250 'C (On) 
Initial temp: 250 'C (On) 
Pressure: 9.70 psi (On) 
Split ratio: 100:1 
Split flow: 119.2 mL/min 
Total flow: 123.1 mL/min 
Gas saver: On 
Saver flow: 20.0 mL/min 
Saver time: 2.00 min 
Gas type: Helium 
COLUMN SIGNAL 
Capillary Column Data rate: 0.1 Hz 
Model Number: Agilent 19091S-433E Type: col comp 
HP-5MS 5% Phenyl Methyl Siloxane Save Data: Off 
Max temperature: 325 'C Zero: 0.0 (Off) 
Nominal length: 30.0 m Range: 0 
Nominal diameter: 250.00 um Fast Peaks: Off 
Nominal film thickness: 0.25 um Attenuation: 0 
Mode: constant flow 
Initial flow: 1.2 mL/min 
Nominal init pressure: 9.71 psi 
Average velocity: 40 cm/sec 
Source: Inlet 
Outlet: MSD 
Outlet pressure: vacuum 
COLUMN COMP 
Use: Valve Box Heater 
VALVES POST RUN 
Post Time: 0.00 min 
TIME TABLE 
Time Specifier Parameter & Setpoint 
MIKE 16 MIN.M Thu May 12 17:06:14 2011 Page: 2 
GC Injector 
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Front Injector: 
Sample Washes 1 
Sample Pumps 2 
Injection Volume 1.00 microliters 
Syringe Size 10.0 microliters 
PreInj Solvent A Washes 2 
PreInj Solvent B Washes 2 
PostInj Solvent A Washes 2 
PostInj Solvent B Washes 2 
Viscosity Delay 0 seconds 
Plunger Speed Fast 
PreInjection Dwell 0.00 minutes 
PostInjection Dwell 0.00 minutes 
Back Injector: 
No parameters specified 
Column 1 Inventory Number : AB001 
MS ACQUISITION PARAMETERS 
 
Solvent Delay : 2.50 min 
EMV Mode : Gain Factor 
Gain Factor : 1.00 
Resulting EM Voltage : 1188 
[Scan Parameters] 
Low Mass : 40.0 
High Mass : 700.0 
Threshold : 150 
Sample # : 1 A/D Samples 2 
Plot 2 low mass : 50.0 
Plot 2 high mass : 550.0 
[MSZones] 
MS Source : 230 C maximum 250 C 
MS Quad : 150 C maximum 200 C 
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APPENDIX II: 1H, 13C NMR  
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